I-MAB logo

I-MAB

NAS:IMAB (China)  
$ 3.14 +0.06 (+1.95%) 04:00 PM EST
P/E:
At Loss
P/B:
0.43
Market Cap:
$ 260.93M
Enterprise V:
$ -299.92M
Volume:
623.50K
Avg Vol (2M):
363.71K
Also Trade In:
Volume:
623.50K
Market Cap $:
260.93M
PE Ratio:
At Loss
Avg Vol (2M):
363.71K
Enterprise Value $:
-299.92M
PB Ratio:
0.43

Business Description

Description
I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. Its first commercial drug will be felzartamab for the China market, a CD38 inhibitor for multiple myeloma, which we estimate will be launched in late 2023 or early 2024. Core assets include lemzoparlimab, a potential best-in-class CD47 inhibitor; uliledlimab, a potential best-in-class CD73 inhibitor; and eftansomatropin, a long-acting growth hormone that has a large market in China among pediatric patients with short stature.
Name Current Vs Industry Vs History
Cash-To-Debt 37.77
Equity-to-Asset 0.81
Debt-to-Equity 0.03
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.61
Distress
Grey
Safe
Beneish M-Score 2.25
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 14.24
9-Day RSI 21.16
14-Day RSI 27.12
6-1 Month Momentum % -8.24
12-1 Month Momentum % -76.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.31
Quick Ratio 7.31
Cash Ratio 6.65
Days Inventory 137.41
Days Sales Outstanding 51.22

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.5

Financials (Next Earnings Date:2023-03-29 Est.)

IMAB's 30-Y Financials

How I-MAB (IMAB) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IMAB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

I-MAB Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 18.776
EPS (TTM) ($) -4.42
Beta 1.09
Volatility % 94.96
14-Day RSI 27.12
14-Day ATR ($) 0.323249
20-Day SMA ($) 3.779
12-1 Month Momentum % -76.22
52-Week Range ($) 2.73 - 21.44
Shares Outstanding (Mil) 83.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

I-MAB Filings

Document Form Filing Date
No Filing Data

I-MAB Stock Events

Event Date Price($)
No Event Data

I-MAB Frequently Asked Questions

What is I-MAB(IMAB)'s stock price today?
The current price of IMAB is $3.14. The 52 week high of IMAB is $21.44 and 52 week low is $2.73.
When is next earnings date of I-MAB(IMAB)?
The next earnings date of I-MAB(IMAB) is 2023-03-29 Est..
Does I-MAB(IMAB) pay dividends? If so, how much?
I-MAB(IMAB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1